<DOC>
	<DOCNO>NCT02441738</DOCNO>
	<brief_summary>Atrial fibrillation ( AF ) common cardiac arrhythmia lifetime risk develop AF 1 4 people age 40 . Besides hemodynamic compromise stroke remains feared complication AF increase risk 5-fold . Catheter ablation evolve standardized treatment option paroxysmal AF . Due advance electrical structural remodel single procedural result catheter ablation persistent longstanding persistent AF rather disappoint without proven superiority apply strategy compare others . However , repeat catheter ablation achieve good result . The surgical ( epicardial ) approach seem effective , though still significant amount failure exist . Checking epicardial ablation line necessary make additional endocardial line ( hybrid ablation ) expect efficacious avoid lesion gap provide complete lesion set . The study objective pilot trial compare safety efficacy repeat catheter ablation within 6 month versus hybrid ablation consist endoscopic epicardial surgery combine endocardial catheter ablation ( perform one-stage ) prevent recurrence atrial fibrillation ( AF ) symptomatic , drug refractory patient persistent longstanding persistent atrial fibrillation .</brief_summary>
	<brief_title>Hybrid Versus Catheter Ablation Persistent AF</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Known history symptomatic persistent AF longstanding persistent atrial fibrillation , Refractory intolerant least one antiarrhythmic drug class I III , At least 18 year age , Mentally able willing give inform consent . Previous ablation procedure , Longstanding persistent AF &gt; 3 year , Paroxysmal atrial fibrillation . Successful cardioversion within 48 hour onset arrhythmia also consider paroxysmal . In patient paroxysmal persistent AF , dominant pattern take categorize , Atrial fibrillation secondary electrolyte imbalance , thyroid disease , reversible noncardiovascular cause , Presence leave atrial appendage ( LAA ) thrombus , Left atrial size ≥ 60mm ( PLAXview TEE ) , Left ventricular ejection fraction &lt; 40 % , In need cardiac surgery AF treatment within 12 month , Intolerance heparin warfarin , Unable undergo TEE , Sicksinussyndrome Mitral valve insufficiency &gt; Iº Carotic stenosis &gt; 80 % , Active infection sepsis , Pleural adhesion , Elevated hemi diaphragm Significant pulmonary dysfunction assess preoperative lung testing , Chronic obstructive pulmonary disease FEV1 VC &lt; 50 % predict History cerebrovascular accident ( CVA ) transient ischemic attack ( TIA ) , History blood clot abnormality , History thoracic radiation , History pericarditis , History cardiac tamponade , History thoracotomy cardiac surgery , Bodymassindex &gt; 40 , Pregnancy , Life expectancy le 12 month , Participation clinical study involve investigational drug device .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Atrial Fibrillation</keyword>
	<keyword>Hybrid Ablation</keyword>
	<keyword>Catheter Ablation</keyword>
</DOC>